Form 4 for BYAH Park Ha Biological Technology Co., Ltd.
Accepted 2026-08-07 08:58:11 ET · period of report 2026-08-03 · accession 0001213900-26-086433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 08:58 | 2026-08-03 | BYAH | Zhu Xiaoyan | CFO | A - Grant | $0.18 | +112.5K | 112.5K | New | +$20.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2026-08-03 | A | A | 112,500 | $0.18 | 112,500 | D | — | — | (F2) On August 6, 2026, Park Ha Biological Technology Co., Ltd. effected a 1-for-8 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. (F1) Purchase of Class A ordinary shares from Park Ha Biological Technology Co., Ltd. pursuant to its 2026 Share Incentive Plan. (F2) On August 6, 2026, Park Ha Biological Technology Co., Ltd. effected a 1-for-8 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. |